EUVIMEDEUVIMED entdecken
Kohortenstudie

Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study

Marvin Koon Sun Pat iD, Meera Manraj, Shyam Manraj

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35172 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Marvin Koon Sun Pat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Community Physician, Ministry of Health and Wellness, Port Louis, Mauritius. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Staging, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is by far the leading cancer both in terms of incidence and mortality in the Republic of Mauritius, a Small Island Developing State (SIDS). However, few studies assessed its survival by age, stage at diagnosis and molecular subtype. We identified 1399 breast cancer cases newly diagnosed between 2017 and 2020 at the Central Health Laboratory, Victoria Hospital. Cancers were categorized into five molecular subtypes: (1) luminal A, (2) luminal B Her2 negative, (3) luminal B Her2 positive, (4) Her2 enriched and (5) Triple negative. The net 1 and 3‐year survival were estimated for different age groups, staging at time of diagnosis and molecular subtype. We also estimated the excess hazards using a multivariate Cox proportional hazards model. While early stage at diagnosis (stage 1 [44.4%] and stage 2 [20.1%]) were most common compared to late presentation (Stage 3 [25.4%] and stage 4 [10.1%]), luminal B Her2 negative (36.7%) was the most frequent molecular subtype. The net 1‐ and 3‐year breast cancer survival rates were 93.9% (92.3–95.4) and 83.4% (80.4–86.4), respectively. Breast cancer three‐year survival rates were poorest among the youngest patients (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasm StagingErb-b2 Receptor Tyrosine KinasesHumansFemaleMiddle AgedRetrospective StudiesAdultAgedMauritiusAge FactorsSurvival AnalysisYoung AdultAged, 80 and overBiomarkers, TumorProportional Hazards Models

Stichwörter der Autor:innen

Republic of MauritiusSub‐Saharan Africabreast cancermolecular subtypesmall island developing countriessurvival analysis

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorERBB2 protein, human

Autor:innen und Institutionen

  • Community Physician, Ministry of Health and Wellness, Port Louis, Mauritius.
  • Faculty of Medicine and Health Science, University of Mauritius, Reduit, Mauritius.
  • Central Health Laboratory, Victoria Hospital, Candos, Mauritius.

ORCID-Profile: Marvin Koon Sun Pat

Zitieren

APA

Koon Sun Pat, M., Manraj, M., & Manraj, S. (2025). Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study. International Journal of Cancer. https://doi.org/10.1002/ijc.35172

Vancouver

Koon Sun Pat M, Manraj M, Manraj S. Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study. International Journal of Cancer. 2025. doi:10.1002/ijc.35172

BibTeX
@article{KoonSunPat2025,
  author = {Koon Sun Pat, Marvin and Manraj, Meera and Manraj, Shyam},
  title = {Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35172}
}
Kostenlos starten →